Bristol James Arthur — SEC Form 4 filings
SEC reporting owner CIK 1715153. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-29 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. | Director | 1 | — | — | 6 |
| Erasca, Inc. (ERAS) | Director | 5 | — | — | 5 |
| Ernexa Therapeutics Inc. (ERNA) | Director | 3 | — | — | 4 |
Form 4 filings — Bristol James Arthur
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Ernexa Therapeutics Inc. (ERNA) | Grant/award (A): 8,320 (derivative) @ $0 · Grant/award (A): 5,083 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 29,888 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 37,762 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Eterna Therapeutics Inc. (ERNA) | Grant/award (A): 72,074 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 45,678 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Erasca, Inc. (ERAS) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Deciphera Pharmaceuticals, Inc. | Disposition to issuer (D): 22,150 (derivative) · Disposition to issuer (D): 67,494 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 9,570 (derivative) · Disposition to issuer (D): 18,500 (derivative) · Disposition to issuer (D): 30,000 (derivative) | EDGAR |
| 2024-04-29 | 4 | Eterna Therapeutics Inc. (ERNA) | Grant/award (A): 124,525 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1715153 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →